AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34

Authors: Roujeau, JC
Citation: Jc. Roujeau, Emergencies in dermatoallergology., REV FR ALLE, 41(3), 2001, pp. 331-335

Authors: Sidoroff, A Halevy, S Bavinck, JNB Vaillant, L Roujeau, JC
Citation: A. Sidoroff et al., Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern, J CUT PATH, 28(3), 2001, pp. 113-119

Authors: Fagot, JP Mockenhaupt, M Bouwes-Bavinck, JN Naldi, L Viboud, C Roujeau, JC
Citation: Jp. Fagot et al., Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis, AIDS, 15(14), 2001, pp. 1843-1848

Authors: Raux, G Gilbert, D Joly, P Martel, P Roujeau, JC Prost, C Lefranc, MP Tron, F
Citation: G. Raux et al., IGHV3-associated restriction fragment length polymorphisms confer susceptibility to bullous pemphigoid, EXP CLIN IM, 18(2), 2001, pp. 59-66

Authors: Crickx, B Grosshans, E Bagot, M Roujeau, JC Revuz, J Faure, M
Citation: B. Crickx et al., Reform of the 2nd part of the 2nd cycle of medical teaching in France, ANN DER VEN, 128(8-9), 2001, pp. 964-967

Authors: Estines, O Revuz, J Wolkenstein, P Bressieux, JM Roujeau, JC Cosnes, A
Citation: O. Estines et al., Sarcoidosis: thalidomide treatment in ten patients, ANN DER VEN, 128(5), 2001, pp. 611-613

Authors: Maubec, E Oberlin, O Belhadj, K Roujeau, JC
Citation: E. Maubec et al., Subcutaneous inflammatory edema induced by MINE chemotherapy, ANN DER VEN, 128(4), 2001, pp. 534-537

Authors: Lorette, G Taieb, A Roujeau, JC Autret-Leca, E
Citation: G. Lorette et al., Lack of evidence-based approach to teaching medicine, ANN DER VEN, 128(4), 2001, pp. 581-584

Authors: Roujeau, JC
Citation: Jc. Roujeau, Clinical criteria and risk factors., ANN DER VEN, 128(3), 2001, pp. 376-381

Authors: Girou, E Azar, J Wolkenstein, P Cizeau, M Brun-Buisson, C Roujeau, JC
Citation: E. Girou et al., Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward, INFECT CONT, 21(9), 2000, pp. 583-587

Authors: Loiseau, P Lecleach, L Prost, C Lepage, V Busson, M Bastuji-Garin, S Roujeau, JC Charron, D
Citation: P. Loiseau et al., HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus, J AUTOIMMUN, 15(1), 2000, pp. 67-73

Authors: Roujeau, JC
Citation: Jc. Roujeau, Neutrophilic drug eruptions, CLIN DERMAT, 18(3), 2000, pp. 331-337

Authors: Roujeau, JC
Citation: Jc. Roujeau, Clinical criteria and risk factors., MED MAL INF, 30, 2000, pp. 399S-405S

Authors: Joly, P Richard, C Gilbert, D Courville, P Chosidow, O Roujeau, JC Beylot-Barry, M D'Incan, M Martel, P Lauret, P Tron, F Descamps, V Thomas, L Merle, C Delaporte, F Raison, N Saiag, P Dandurand, M Franck, N Petit, A Bazex, J Vaillant, L Bernard, P Sassolas, B
Citation: P. Joly et al., Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus, J AM ACAD D, 43(4), 2000, pp. 619-626

Authors: Bouloc, A Joly, P Saint-Leger, E Wechsler, J Roujeau, JC Revuz, J
Citation: A. Bouloc et al., Paraneoplastic pemphigus with circulating antibodies directed exclusively against the pemphigus vulgaris antigen desmoglein 3, J AM ACAD D, 43(4), 2000, pp. 714-717

Authors: Roujeau, JC Bonnetblanc, JM
Citation: Jc. Roujeau et Jm. Bonnetblanc, Selected papers of the College des Enseignants de Dermato-Venereologie de France, ANN DER VEN, 127, 2000, pp. A6-A6

Authors: Bachot, N Roujeau, JC
Citation: N. Bachot et Jc. Roujeau, Drug eruption: assessment of causality, ANN DER VEN, 127(5), 2000, pp. 542-545

Authors: Roujeau, JC
Citation: Jc. Roujeau, Epidermic necrolysis: advances in pathogenesis, ANN DER VEN, 127(5), 2000, pp. 546-547

Authors: Roujeau, JC
Citation: Jc. Roujeau, Epidemiology tools in dermatology, ANN DER VEN, 127(3), 2000, pp. 261-265

Authors: Bastuji-Garin, S Fouchard, N Bertocchi, M Roujeau, JC Revuz, J Wolkenstein, P
Citation: S. Bastuji-garin et al., SCORTEN: A severity-of-illness score for toxic epidermal necrolysis, J INVES DER, 115(2), 2000, pp. 149-153

Authors: Le Cleach, L Delaire, S Boumsell, L Bagot, M Bourgault-Villada, I Bensussan, A Roujeau, JC
Citation: L. Le Cleach et al., Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors, CLIN EXP IM, 119(1), 2000, pp. 225-230

Authors: Beneton, N Wolkenstein, P Bagot, M Cosnes, A Wechsler, J Roujeau, JC Revuz, J
Citation: N. Beneton et al., Amicrobial pustulosis associated with autoimmune diseases: healing with zinc supplementation, BR J DERM, 143(6), 2000, pp. 1306-1310

Authors: Garcia-Doval, I LeCleach, L Bocquet, H Otero, XL Roujeau, JC
Citation: I. Garcia-doval et al., Toxic epidermal necrolysis and Stevens-Johnson syndrome - Does early withdrawal of causative drugs decrease the risk of death?, ARCH DERMAT, 136(3), 2000, pp. 323-327

Authors: Dupuy, A Benchikhi, H Roujeau, JC Bernard, P Vaillant, L Chosidov, O Sassolas, B Guillaume, JC Grob, JJ Bastuji-Garin, S
Citation: A. Dupuy et al., Risk factors for erysipelas of the leg (cellulitis): case-control study, BR MED J, 318(7198), 1999, pp. 1591-1594

Authors: Roujeau, JC
Citation: Jc. Roujeau, Physiopathology and management of toxic epidermal necrolysis, ARCH PED, 6, 1999, pp. 296S-298S
Risultati: 1-25 | 26-34